-
Product Insights
GMP Grp/ Trinseo – Polystyrene Recycling Plant – Netherlands
Equip yourself with the essential tools needed to make informed and profitable decisions with our GMP Grp/ Trinseo - Polystyrene Recycling Plant - Netherlands report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into...
-
Product Insights
New![]()
Net Present Value Model: Teva Pharmaceutical Industries Ltd’s Golimumab Biosimilar
OverviewDetermining the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the current market, and knowledge of expected cash inflows, outflows, and potential success rates for each stage of drug development. GlobalData has done all of this work for you, Drugs Intelligence database to create high-value, risk-adjusted NPV models. Teva Pharmaceutical Industries Ltd's Golimumab Biosimilar Drug Details: Monoclonal antibody is under development for the treatment of inflammation, rheumatoid arthritis and musculoskeletal diseases. The...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Golimumab Biosimilar in Rheumatoid Arthritis
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Golimumab Biosimilar in Rheumatoid ArthritisDrug Details:Monoclonal antibody is under development for the treatment of inflammation, rheumatoid...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Golimumab Biosimilar in Inflammation
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Golimumab Biosimilar in Inflammation Drug Details:Monoclonal antibody is under development for the treatment of inflammation, rheumatoid...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Ustekinumab Biosimilar in Plaque Psoriasis (Psoriasis Vulgaris)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Ustekinumab Biosimilar in Plaque Psoriasis (Psoriasis Vulgaris) Drug Details:ustekinumab biosimilar is under development for the treatment...
-
Company Profile
![]()
Fusion Pharmaceuticals Inc – Company Profile
Fusion Pharmaceuticals Inc (Fusion Pharmaceuticals) is a clinical-stage biopharmaceutical company which develops targeted alpha-particle radio therapeutics for the treatment of cancers. It offers pipeline products such as FPI-1434, FPI-2059 and FPI-1966. The company’s pipeline products are to treat multiple cancers like head and neck bladder cancer, colorectal cancer and gastric cancers. Fusion Pharmaceuticals carters its products under brand Keytruda. The company is a spin-off from the Centre for Probe Development and Commercialization (CPDC), a leading radiopharmaceutical research and GMP production...
Add to Basket -
Sector Analysis
United States (US) Renewable Energy Policy Handbook, 2023 Update
"United States (US) Renewable Energy Policy Handbook, 2023 Update” is among the latest country specific policy reports from GlobalData, the industry analysis specialist. The report offers comprehensive information on major policies governing the renewable energy market in the country and provides information on renewable policies/developments at a regional/municipal level. The report discusses renewable energy targets and plans along with the present policy framework, giving a fair idea of overall growth potential of the renewable energy industry. The report also provides...
-
Company Profile
![]()
Sopharma AD – Company Profile
Sopharma AD (Sopharma) focuses on the manufacturing of pharmaceutical products and distribution of health related products. The company is also involved in non-pharma activities which includes manufacturing of consumables, dressing materials, apparatus, manufacturing of plastic disposable materials for the hospital market. It is also involved in the manufacturing of infusion solutions, injection solutions and veterinary medical products. Sopharma is specialized in manufacturing of non-sterile liquids/solutions, sterile dosage forms and manufacturing of semisolid and solid dosage form. The company also offers...
Add to Basket -
Company Profile
![]()
Bio-Techne Corp – Company Profile
Bio-Techne Corp (Bio-Techne) manufactures, develops and markets biotechnology products and scientific tools to understand biological processes and drive research. The company’s product portfolio includes ELISA kits, ELISpot kits, enzymes, Luminex assays, proteins, GMP products and instruments. Bio-Techne's custom service offerings comprise antibody services, targeted protein degradation services, licensing, cell and gene therapy services, compound library services, ELISA services and gene engineering services among others. It conducts research in the areas of cancer, cardiovascular, cell and gene therapy, covid-19, glycobiology, immunology,...
Add to Basket -
Company Profile
![]()
Tilray Inc – Company Profile
Tilray Brands Inc (Tilray) is a pharmaceutical company that focuses on cannabis research, processing, cultivation, and distribution. The company is a Good Manufacturing Practice (GMP) certified company that produces and supplies adult-use cannabis products, medicinal cannabis products, and hemp products among others. Tilray cultivates a wide range of strains including hemp foods and cannabidiol-rich varieties. The company operates under the brand Tilray. It operates through subsidiaries present in Australia, Canada, Chile, France, New Zealand, Portugal, Ireland, Japan, the Netherlands and...
Add to Basket -
Company Profile
![]()
Emerald Health Therapeutics Inc – Company Profile
Emerald Health Therapeutics Inc (Emerald Health), formerly T-Bird Pharma Inc, is a producer of pharmaceutical grade medical cannabis. It extracts and markets dried cannabis, and cannabis oils and capsules. It offers cannabinoid medicines, which are present in an unparalleled opportunity for use as therapeutic alternatives to a multitude of conventional pharmaceutical medicines. The company also provides pharmaceutical research and development, clinical development, clinical research, house extraction, GMP production practices, regulatory approval processes and others. Emerald Health is headquartered in Victoria,...
Add to Basket -
Company Profile
![]()
PPD Inc – Company Profile
PPD Inc (PPD) is a pharmaceutical company that carries out the drug development, laboratory and lifecycle management services. It offers clinical development and laboratories solution. The company's clinical services include early development, clinical trial management, biostatics, peri- and post-approval, site and patient-centric solutions, product development and consulting, technology and innovation, decentralized clinical trials, information security and preclarus, among others. PPD's laboratories services include bioanalytical lab, bioanalytical lab experience and expertise, biomarker lab, biomarker lab resource, central lab, central lab capabilities,...
Add to Basket -
Company Profile
![]()
Hangzhou Tigermed Consulting Co Ltd – Company Profile
Hangzhou Tigermed Consulting Co Ltd (Tigermed) is a contract research organization (CRO) that provides clinical trial services. It offers regulatory submission and approval, medical translation and GMP (Good Manufacturing Practice) consulting, medical monitoring, project management, medical device testing, patient recruitment, clinical evaluation and development, data management, biostatistics and statistical programming services. The company also provides integrated technology services including site management, pharmacovigilance, third-party audit and training, medical imaging and clinical trial system solutions. Tigermed conducts research in the therapeutic areas...
Add to Basket -
Thematic Analysis
![]()
Cloud Computing in Retail and Apparel – Thematic Intelligence
Retailers can reduce IT costs while streamlining processes, increasing efficiency, and improving user experience by integrating cloud computing services into their businesses. Many retailers have also created in-house cloud divisions to leverage the technological capabilities of cloud. The cloud computing in retail & apparel thematic intelligence report provides an in-depth look at the importance of the cloud to the retail and apparel sector. The value chain section provides an in-depth description of each segment of the cloud and outlines the...
-
Product Insights
![]()
Likelihood of Approval and Phase Transition Success Rate Model – ustekinumab biosimilar
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry ustekinumab biosimilar Drug Details ustekinumab biosimilar is under development for the treatment of crohn...
-
Thematic Analysis
![]()
Robotics in Retail and Apparel – Thematic Intelligence
Robotics in Retail and Apparel Thematic Report Overview Robotics is gaining prominence across multiple industries. High-growth industry leaders have streamlined their logistics and supply chain networks by incorporating robotics into their processes. While requiring upfront investment, robotics in warehouses significantly reduces operating expenses, driving efficiency and accuracy. The robotics in retail and apparel thematic intelligence report assesses how robotics, combined with other emerging technologies, can be used across the retail and apparel value chain. It provides an overview of the...
-
Product Insights
Kaposi Sarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
The symptoms of Kaposi Sarcoma include patches that are usually red or purple and are made of cancer cells and blood cells. Lesions that develop in the stomach and intestines can cause abdominal pain and diarrhea. The Kaposi Sarcoma pipeline market research report provides comprehensive information on the therapeutics under development for Kaposi Sarcoma, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive...
-
Sector Analysis
United States of America (USA) Solar Thermal Power Market Size and Trends by Installed Capacity, Generation and Technology, Regulations, Power Plants, Key Players and Forecast, 2022-2035
The United States of America (USA) solar thermal power market capacity installation was valued at 1.56 GW in 2021 and is expected to achieve a CAGR of less than 1% during 2021-2035. The US solar thermal power market research report offers comprehensive information and an understanding of the solar thermal power market in the US. The report discusses the renewable power market in the country and provides forecasts for up to 2035. It also highlights installed capacity and power generation...
-
Product Insights
Specific Proteins Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update
Specific Proteins are reagents and test kits that are used to quantify and detect protein molecules from bodily fluids. The Specific Proteins pipeline market research report provides comprehensive information about the Specific Proteins pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
-
Product Insights
Protein Kinase C Epsilon Type (nPKC Epsilon or PRKCE or EC 2.7.11.13) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
The Protein Kinase C Epsilon Type pipeline drugs market research report outlays comprehensive information on the Protein Kinase C Epsilon Type (nPKC Epsilon or PRKCE or EC 2.7.11.13) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA), and molecule type that are being developed by companies/universities. The report also reviews key players involved in Protein Kinase C Epsilon Type (nPKC Epsilon or PRKCE or EC 2.7.11.13) targeted therapeutics development with respective...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.